Search Results
Found 59 results for "pharma" across articles, medicines, trials, companies and the glossary
Clinical trials in IrelandTracker →
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With…Recruiting · Alnylam Pharmaceuticals
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart…Recruiting · Merck Sharp & Dohme LLC
Chemokeyp: A Feasibility Study for Realtime Safety Data-Capture for Potential Serious Adv…Recruiting · St Vincent's University Hospital, Ireland
A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18…Recruiting · Ascendis Pharma A/S
Industry
The Cost-Governed Enterprise: A Financial Governance Playbook for AI in Irish Life Sciences
MIT research found that 95% of enterprise generative AI pilots show no measurable P&L impact, despite up to €36.8bn of global investment. The failure is not the technology, it is governance: cost is billed and legible, return is diffuse and uninstrumented. A seven-band cost taxonomy, eight load-bearing equations and the make-versus-rent crossover that Irish life sciences boards need to close the gap.
Industry
AI in Pharma H1 2026 Report: Mega-Deals, On-Premise Supercomputer Factories, and Clinical Translation Milestones
A comprehensive half-year update on artificial intelligence in pharmaceutical drug discovery, detailing Isomorphic's $2.1B Series B, Insilico's multi-billion partnerships, NVIDIA's private AI factories, and Phase I/II clinical pipeline progress.
Industry
Using LLMs Safely in Pharma: The Employee Guide to Risk Mitigation, Ethics, and GxP Compliance
An authoritative enterprise guide for pharmaceutical professionals on using Large Language Models (LLMs) safely, mitigating hallucination and data privacy risks, ensuring GxP and EU AI Act compliance, and establishing human-in-the-loop workflows.
Industry
US Pharmaceutical Tariffs Update: Policy Realities, The Stockpile 'Unwind', and Ireland’s Strategic Position
An in-depth analysis of where US pharmaceutical tariff policies stand in mid-2026 under the Trump administration, analyzing recent CSO export data, inventory stockpiling corrections, MFN agreements, and Ireland’s strategic biopharma position.
Industry
US Biopharma Group Pfanstiehl Acquires Nestlé’s Former Askeaton Infant Formula Site in Landmark Mid-West Industrial Transition
In a major boost for Ireland’s Mid-West life sciences hub, US biopharma specialist Pfanstiehl has acquired Nestlé’s former Wyeth Nutritionals plant in Askeaton, Co. Limerick, establishing its first international manufacturing facility.
Industry
High Expectations, Historic Opportunity: What Ireland’s Rotating EU Council Presidency Can Deliver for European and Irish Pharma
A Priya Life Science White Paper analyzing the pivotal policy dossiers of the 2026 Irish Presidency, the economic stakes for biopharma manufacturing, and key strategic recommendations.
Industry
The Resource Equation: Decoupling Water, Power, and the Shift in Ireland’s Data Centre and Life Sciences Footprint
An in-depth, fact-based analysis of water and power consumption across Ireland’s twin industrial pillars, the infrastructure bottlenecks, and the shifting geography of high-tech construction.
Industry
Quantum 2030: How Ireland’s New Strategic Blueprint Aims to Secure Global Leadership in Quantum Computing
The Irish Government launches "Quantum 2030", a whole-of-government national strategy designed to position Ireland as an internationally competitive hub in quantum technologies, research, and talent by 2030.
Industry
UK Pharma CV Guide 2026: MHRA Standards, Golden Triangle Hubs & Free ATS CV Builder
Complete 2026 guide to writing an ATS-compliant pharmaceutical CV in the UK. Features MHRA & ABPI standards, UK 2-page CV conventions, Golden Triangle recruitment benchmarks, and free ATS CV Studio tools.
Industry
US Pharma Resume Guide 2026: FDA cGMP Standards, ATS Formats & Free Builder
Master the US pharmaceutical resume format in 2026. Covers FDA 21 CFR compliance terms, 1-2 page US resume rules, major US biopharma hubs (Boston, SF Bay, NJ, NC Triangle), and free ATS resume tools.
Industry
Global Pharma Talent Corridor: Writing a Cross-Border CV for India, Ireland, UK & US Roles
The ultimate 2026 guide for international life science professionals moving between India, Ireland, the UK, and the US. Learn how to format GxP experience, CDMO backgrounds, and visa-ready ATS CVs.
Industry
ABPI Impact Map Highlights £20.4B Pharma Footprint as UK-Ireland Supply Chain Synergies Deepen
The ABPI launches its updated 2026 Pharmaceutical Impact Map, revealing a £20.4bn economic contribution, 125,702 skilled jobs, and 3,658 NHS collaborations across the UK, while underscoring vital cross-border manufacturing and trade synergies with Ireland.
Industry
GEODIS Expands European Logistics Network with 2,000-Pallet Temperature-Controlled Manchester Pharma Hub
GEODIS opens a state-of-the-art GDP-compliant pharmaceutical hub in Sharston Green, South Manchester, offering 2,000 pallet positions, 15–25°C and 2–8°C climate-controlled storage, and direct air/sea connectivity to Ireland and global markets.
Industry
Registrations Open for TechIreland National AI Challenge 2026: Agentic Workflows, Regional Hubs, and Ecosystem Collaboration
Registrations are now open for the 2026 TechIreland National AI Challenge, delivered in partnership with CeADAR, Enterprise Ireland, and the European Digital Innovation Hubs Network. Learn about the 2026 theme "AI & Agents", key deadlines, regional hubs, and how to register.
Biotechnology
Ireland's Biopharma Manufacturing Hub: A Master Guide to Tax, Talent, CDMO Sourcing, and Regulatory Excellence
An in-depth analysis of Ireland's evolution into Europe's second-largest exporter of medicinal products. Discover how a 12.5% tax structure, NIBRT bioprocessing excellence, HPRA regulatory trust, and a thriving CDMO ecosystem make Ireland the premier location for global drug production.
Industry
Master the Ireland & EU Pharma CV in 2026: HPRA Standards, ATS Templates & Industry Examples
The definitive 2026 guide to writing an ATS-compliant biopharmaceutical CV in Ireland and the EU. Features HPRA & EU Annex 1 standards, GxP bullet point formulas, Irish regional hub insights, and free ATS CV Studio tools.
Industry
Enterprise Ireland Funding Programmes 2026: The Complete Founder’s Guide to Grants, Pre-Seed (PSSF), iHPSU & Founder Visas
Master Enterprise Ireland's funding ecosystem: from Pre-Seed Start Fund (€50k-€100k) and Innovative HPSU Fund (€1.2M) to R&D, Green, and Digitalisation vouchers. Includes step-by-step application advice, readiness timelines, and non-EU founder visa rules.
Industry
The €8.5 Billion Defense: Dutch Innovative Pharma Fights Back Against Cost-Control Policies
The Dutch Association for Innovative Medicines (VIG) releases a detailed report highlighting the sector\'s €8.5 billion gross added value, warning that cost-containment measures threaten patient access, clinical trials, and Europe\'s biopharma sovereignty.
Regulatory Affairs
After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA
A commercial-grade blueprint for the Ireland-India pharma corridor under the EU-India FTA: tariffs, HPRA-CDSCO bridges, 2030 projections, policy asks.
Regulatory Affairs
The UK-India CETA: A Deep Dive into Bilateral Pharmaceutical Value Chains, API Trade, and Medicine Price Trajectories
An in-depth commercial analysis of the UK-India Comprehensive Economic and Trade Agreement (CETA), exploring its transformative impact on bilateral pharmaceutical manufacturing, active pharmaceutical ingredient (API) supply chains, and consumer medicine pricing.
Biotechnology
Bilateral Breakthrough: How the Historic UK-India Free Trade Agreement Transforms Life Sciences and Key Trade Sectors
The historic UK-India Comprehensive Economic and Trade Agreement (CETA) and Double Contributions Convention have officially entered into force, opening duty-free access for pharmaceuticals, dismantling high tariffs on manufacturing inputs, and eliminating dual social security taxes for mobile professionals.
Regulatory Affairs
Transatlantic Tariff Siege: EU Pushes US for €150B Exemption List to Protect MedTech and Spirits
As the Turnberry Deal’s 15% tariff baseline takes hold, Brussels has formally requested carve-outs for €150 billion worth of European goods. The stakes are exceptionally high for Ireland’s €13B medical technology industry, where critical components face severe transatlantic margin pressures.
Regulatory Affairs
GEODIS Expands Pharmaceutical Logistics in Poland: Securing Dual GDP and IATA CEIV Pharma Certifications
GEODIS has renewed its IATA CEIV Pharma accreditation in Warsaw and secured GDP certification for its Stryków Dobra contract logistics facility. This dual compliance milestone bolsters Poland’s status as a critical gateway in Europe’s pharmaceutical supply chain.
Biotechnology
Normalization or Correction? Ireland’s Goods Exports Drop 29% in May as Pharma Surplus Narrows
Ireland’s goods exports fell by 29.1% to €16.5 billion in May 2026, driven by a €8 billion drop in pharmaceutical shipments, while imports rose 17.5% to €13.1 billion, narrowing the trade surplus.
Biotechnology
MGS Mfg. Group Scales Up European Healthcare Manufacturing with 115,000 Sq Ft Leixlip Hub
MGS Mfg. Group completes a major 115,000 sq ft expansion of its Leixlip, Ireland facility, boosting ISO Class 7 and 8 cleanroom capacity, advanced automation, and controlled "whiteroom" environments to meet surging European medical device and pharmaceutical demands.
Regulatory Affairs
Irish EU Council Presidency Prioritizes €10B Biotech Act to Revitalize European Clinical Trials and Sovereign Biomanufacturing
Irish Health Minister Jennifer Carroll MacNeill positions the €10 billion EU Biotech Act as a key priority for Ireland's Council Presidency, aiming to reverse the decline in clinical trials while balancing pharmaceutical incentives against patient access to affordable therapies.
Regulatory Affairs
Addressing the 801-Day Lag: Ireland’s Drug Approval System Demands Urgent Structural Reform
The latest EFPIA Patients W.A.I.T. Indicator report reveals that Irish patients wait an average of 801 days to access newly approved medicines, prompting calls for an overhaul of the HSE and NCPE reimbursement processes and a dedicated mechanism for rare disease orphan drugs.
Industry
Beyond Google: Why B2B Pharma is Adopting 'Search Everywhere' and Generative Engine Optimization (GEO) in 2026
As professional buyers shift from search engines to AI assistants and LinkedIn for vendor research, B2B pharmaceutical and life science companies are pivoting from traditional keyword rankings to "Search Everywhere" and Generative Engine Optimization (GEO).
Industry
University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre
The University of Galway has been chosen to lead the new €64.5 million Research Ireland Rinn Medical Devices Centre as part of a landmark €460 million government investment in seven new national Rinn research centres.
Industry
Chanelle Pharma Renews Historic Partnership with Galway Races Summer Festival 2026
Chanelle Pharma has confirmed the renewal of its long-standing partnership with the Galway Races Summer Festival for 2026, marking 41 consecutive years of sponsoring the prestigious Leading Trainer Award alongside the Best Turned Out Series.
Industry
The Distortion of Irish GDP: How 'Phantom Exports' Are Reshaping the Biopharma Landscape
Ireland's contract manufacturing exports-colloquially known as "phantom exports"-are surging once again, raising fresh questions about the decoupling of headline economic figures from the domestic life sciences economy.
Pharmaceutical
The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit
The FDA CBER warning letter issued to Genzyme Ireland’s Waterford site in June 2026 is a watershed moment for Irish biopharma. From 11x repeated filter tests to discarded checklists and unexplained deviation cancellations, we analyze the specific CGMP violations and detail what this compliance failure means for quality management across the sector.
Pharmaceutical
The Complete LinkedIn Brand-Building Playbook for Pharma and Life Sciences
LinkedIn is the most powerful platform for pharmaceutical and life sciences professionals to build authority and reach target customers. This complete guide covers company page setup, what to post, best times to publish, how to grow connections, and how to turn LinkedIn into a consistent pipeline.
Pharmaceutical
The Newsletter Advantage: How Pharma Companies Use Email to Reach the Right People Every Time
Newsletters are the most cost-effective marketing tool for pharmaceutical companies. Unlike social media, a newsletter lands directly in the inbox of every person who chose to hear from you. This step-by-step guide explains how to set one up, what to put in it, and how to reach target customers efficiently.
Biotechnology
The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition
In a deal announced on July 7, 2026, Woodberry Packaging - the Dublin-backed packaging group led by veteran entrepreneur Patrick Doran - has acquired Medica Packaging, the UK's largest independent pharmaceutical carton converter, and F.G. Curtis, a respected name in cosmetics and personal care packaging. The combined group now employs 650 people across the UK and Ireland with revenues exceeding €120 million, marking a significant consolidation moment in the specialist packaging sector.
Regulatory Affairs
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected
Jefferies has revised its debut-quarter US sales estimate for Eli Lilly's oral GLP-1 drug Foundayo (orforglipron) down to $71 million - well below the Wall Street consensus of $130 million and sharply below its own prior estimate of $85 million. With weekly prescriptions hovering around 20,000 and Novo Nordisk's oral Wegovy outpacing it on trajectory, the first oral non-peptide GLP-1 for obesity is generating a very different story than the hype suggested.
Regulatory Affairs
Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots
The UK government and the pharmaceutical industry have launched a series of pilot schemes designed to accelerate NHS patient access to innovative medicines - a direct consequence of the US-UK pharmaceutical trade arrangement that has already rewritten the terms of how Britain prices, approves, and funds new drugs. But with a BMJ analysis warning of £45 billion in diverted NHS resources and up to 229,000 excess deaths by 2036, the pilots are arriving in the middle of one of the most contested healthcare policy disputes in a generation.
Regulatory Affairs
Data Integrity and Quality Oversight: Analyzing the FDA Warning Letter for Sanofi's Waterford Site
Following a January 2026 inspection, the FDA has issued a formal warning letter to Genzyme Ireland Limited in Waterford, citing data integrity concerns, uncontrolled checklists, and quality unit oversight gaps in the manufacturing of Thymoglobulin and Altuviiio.
Regulatory Affairs
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals
In a landmark world-first, Irish-founded Chanelle McCoy Health has received official regulatory approvals from the Saudi Food and Drug Authority and confirmation of safety under EU Novel Food guidelines for its Pureis® Ultra Pure CBD range.
Regulatory Affairs
The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026
A comprehensive technical report detailing the top 10 trends in Good Manufacturing Practice (GMP), sterile manufacturing, GAMP 5, Quality 4.0, and continuous manufacturing currently reshaping the global pharmaceutical landscape.
Regulatory Affairs
FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings
The FDA has issued a formal warning letter to Sanofi's Waterford facility, Genzyme Ireland Limited, citing data integrity breaches, discarded quality records, and botched deviation investigations in the production of haemophilia drug Altuviiio and transplant therapy Thymoglobulin.
Pharmaceutical
Cold Chain Management and Good Distribution Practice (GDP) for Biologics and Vaccines
An academic analysis of temperature-sensitive supply chains, GDP compliance, distribution monitoring, and shipping deviation management.
Regulatory Affairs
Understanding the Common Technical Document (CTD) Structure for Global Regulatory Submissions
An explanation of the 5 modules of the ICH Common Technical Document (CTD) format required for global drug marketing authorization applications.
Regulatory Affairs
Navigating Global Price Controls: How the US Inflation Reduction Act and Evolving EU Policies Shape R&D in 2026
As global health systems enforce tighter pricing controls under the US IRA and EU health technology updates, biopharma majors are restructuring their R&D portfolios to manage clinical risks.
Pharmaceutical
An Introduction to Lyophilization (Freeze-Drying) Technology and Cycle Development in Biopharma
An academic analysis of the freeze-drying process, sublimation phases, critical chamber controls, and lyophilized formulation parameters.
Regulatory Affairs
Data Integrity in the Pharmaceutical Quality Control Laboratory: ALCOA+ Principles Explained
An educational review of data integrity requirements in pharma QC, covering ALCOA+ principles, audit trails, and data security.
Regulatory Affairs
Out of Specification (OOS) Investigations: Step-by-Step Root Cause Analysis and CAPA Guidelines
A structured tutorial on handling quality control laboratory OOS results, conducting Phase I/II investigations, and implementing corrective actions.
Regulatory Affairs
Therapeutic Hotspots of 2026: Evolving Pipelines in Antibody-Drug Conjugates (ADCs) and GLP-1 Obesity Platforms
Global research pipelines and venture capital inflows are concentrating in targeted cancer therapy with ADCs and next-generation cardiometabolic GLP-1 oral weight-loss compounds.
Regulatory Affairs
Computer Systems Validation (CSV): Implementing the GAMP 5 Lifecycle Framework in Modern Plants
A guide to validating computerized lab and production systems using the GAMP 5 V-model lifecycle, risk assessments, and electronic records compliance.
Pharmaceutical
Master's in Pharmacy & Pharmaceutical Sciences in Ireland: Complete 2026 Guide for International Students
An exhaustive guide detailing postgraduate Level 9 pharmaceutical master's programs across Irish universities, covering tuition fees, eligibility criteria, and requirements for international applicants.